HORACE MANN EDUCATORS CORPORATION (HMN): what the price requires

At today's price, HORACE MANN EDUCATORS CORPORATION (HMN) is priced for 10.2% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/HMN

Headline

FieldValue
TickerHMN
CompanyHORACE MANN EDUCATORS CORPORATION
Current price$52.67/sh
CompositionProperty & Casualty 45% / Life & Retirement 36% / Supplemental & Group Benefits 19%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed10.2%
Return on equity now10.9%
ROE gap-0.7pp
Price-to-book1.45x

Solve inputs: computed at a 8.3% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.5pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.80σ
cohort percentile (of 80 peers)38
sustained it ~10 years at this level75%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.11x3expensive
Earnings0.82x2justifies
Relative1.10x3expensive
Growth1.18x2expensive

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.5%); the inversion above states its own rate.

Per-Model Detail (n=10)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$45.471.16xyesTBVPS $31.01 × 1.47x (ROE (TTM) 11.2% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$46.531.13xyesP/E 11x (static sector reference · 2026-04), scenarios: 9.2x / 11.0x / 12.8x (bear / base = reference held flat / bull), EV/EBITDA 22x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$50.271.05xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$43.321.22xyesBV/sh $35.68, ROE (TTM) 11.2%, ke 9.3%
Two-Stage Excess ReturnAsset$47.551.11xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$39.941.32xyesRev $1.7B, growth 5% (input: historical growth; tapered), Terminal P/S: 1.1x / 1.3x / 1.5x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$47.761.10xyesEPS $3.98, growth 2% (input: historical EPS growth), PEG=6.91 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$56.530.93xyes√(22.5 × EPS $3.98 × BVPS $35.68) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$128.420.41xyesEPS $3.98 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$149.250.35xyesEPS $3.98 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$43.031.22xyesEPS $3.98 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-0.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

What the market is paying for Horace Mann is a steady, mid-teens return on its capital, and the company has just shown it can deliver more than that. At today's price the stock changes hands around 1.3 times book value, a level that assumes the insurer sustains a return on equity near 9.8%. The actual numbers have run ahead of that: trailing core return on equity reached 12.7% in Q1 2026, up from 10.6% a year earlier and a long climb from 4.9% in 2023. When a business earns a return comfortably above what its price assumes, the gap between the two is the bull case in its purest form.

The engine behind the improvement is underwriting discipline in the property and casualty book. The first-quarter combined ratio came in at 83.3%, an improvement of more than five points over the prior year, which for an insurer is the cleanest possible signal: it means premiums collected exceeded claims and expenses by a wide margin, and the underwriting itself, not just investment income, is generating profit. The niche focus is what makes that durable. Horace Mann sells to teachers through school partnerships and association endorsements, a captive, loyal, low-churn customer base that mass-market direct marketers find hard to penetrate, and the filing identifies those endorsements and marketing agreements with education associations as a core advantage.

Management has set out a credible path and is returning capital along the way. It maintained full-year 2026 core EPS guidance of $4.20 to $4.50, set a three-year core EPS growth goal of 10% a year, and targets a sustainable return on equity of 12% to 13%. The share count has edged lower, and the stock sits in the lower half of its insurance peer group on price-to-book despite earning a competitive return. The bull case is a specialty insurer whose profitability has genuinely inflected, priced at a discount to peers for a return it is already exceeding.

Bear Case

For an insurer, the bear case lives in two places that do not show up in a single quarter: the adequacy of the reserves set aside for future claims, and the discipline of how capital gets deployed. A combined ratio of 83.3% is excellent, but it is also unusually low for a property and casualty book, and the question a skeptic asks is whether it reflects a genuinely benign claims environment that will normalize. Management's own long-term target is a combined ratio in the low-to-mid 90s, which is to say the company expects underwriting margins to compress from the current level back toward a more normal range. Underwriting today that is mid-90s tomorrow is a meaningful step down in the profit each premium dollar produces.

The structural exposure is catastrophe risk, and it is the kind that can undo years of careful underwriting in a single season. Horace Mann is candid that increased weather-related catastrophes could lead to higher overall losses, which we may not be able to recoup, particularly in a highly regulated and competitive environment, and higher reinsurance costs. A property and casualty insurer is short volatility by design: it collects steady premiums and pays out lumpy, correlated losses when storms hit. The recent ROE improvement was earned in a period without a major catastrophe; one bad year reminds shareholders that the smooth earnings line is an average over events that are anything but smooth.

The competitive backdrop pressures the very niche the bull case rests on. The 10-K acknowledges that the company competes against far larger insurers, GEICO, Progressive and USAA, many of which feature direct marketing distribution, plus technology start-ups, and concedes that its low-cost approach may put us at a competitive disadvantage relative to other more highly rated insurance companies. The educator endorsements are real but renewable, not permanent; lose a national association agreement and the distribution advantage erodes. With the price already assuming a sustained high-single-digit to low-teens return, there is little room for the combined ratio to normalize, a catastrophe to land, and capital to be deployed at anything less than the disciplined rate the recent results imply. The bear case is not that Horace Mann is poorly run; it is that the price extrapolates a peak-discipline, low-catastrophe stretch as the new baseline.

Valuation

An insurer is worth the return it earns on its capital, so the right lens is price-to-book, not an earnings multiple, and on that lens Horace Mann trades around 1.3 times book. That price embeds a sustained return on equity near 9.8%. The useful comparison is to what the company has actually been earning: a trailing core return on equity of 12.7% in the most recent quarter, and management's stated sustainable target of 12% to 13%. The price, in other words, is assuming a return below both the recent result and the company's own goal, which is the opposite of a stretched valuation.

The families of method agree, which is reassuring for a value read. The asset-based, earnings-power, peer-multiple, and growth approaches all support the current price, and the stock sits in the lower half of its insurance peer group on price-to-book. When every standard frame backs the price and the company earns above the implied return, the valuation is doing its job by flagging a name the market is pricing conservatively. The catch, and it is the same one the bear case raises, is that the implied 9.8% return is plausible precisely because the combined ratio is expected to normalize from today's exceptional 83.3% toward the low-to-mid 90s.

The right solvency frame here is not corporate leverage but regulatory capital and payout capacity, because this is a float-funded balance sheet where debt is funding rather than corporate gearing. Horace Mann generates earnings well in excess of its dividend, leaving room for both the payout and buybacks, and the capital position supports the growth the guidance implies. The valuation question is therefore narrow and answerable: if the company sustains a return even near its 12% to 13% target rather than the 9.8% the price assumes, the 1.3-times-book multiple understates the business. The risk is not solvency; it is whether the recent profitability inflection is the new normal or a cyclically favorable moment.

Catalysts

The Q1 2026 report, released in early May, was a record-earnings story. Horace Mann posted net income of $41 million, or $1.00 per share, and record first-quarter core earnings of $53 million, or $1.28 per share, lifting trailing core return on equity to 12.7% from 10.6% a year earlier. The standout was the property and casualty combined ratio of 83.3%, an improvement of more than five points over the prior year, evidence that the underwriting turnaround that began in 2023 is holding. The headline EPS beat even as revenue came in light, a reminder that for an insurer the margin matters more than the top line.

The forward agenda is set by the targets management reaffirmed. It maintained full-year 2026 core EPS guidance of $4.20 to $4.50, representing $175 million to $187 million of after-tax core earnings, and reiterated a three-year core EPS growth goal of 10% a year and a sustainable return on equity target of 12% to 13%. Longer term, it framed segment goals of a combined ratio in the low-to-mid 90s for property and casualty, a 39% benefit ratio for supplemental and group benefits, and a 220 to 230 basis point net interest spread for life and retirement. The key things to watch across the next several quarters are whether the combined ratio holds near current levels or drifts toward the normalized target, the catastrophe experience through storm season, and whether return on equity stays inside the 12% to 13% band the company is now promising.

Peer Cohorts (Per Segment, With Filing Citations)

Property & Casualty (reported)

Life & Retirement (reported)

Supplemental & Group Benefits (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release

View the full interactive HMN report on boothcheck